- Home
- SBSI vs MDXG Comparison
SBSI vs MDXG Comparison
Compare SBSI & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBSI
- MDXG
- Stock Information
- Founded
- SBSI 1960
- MDXG 2006
- Country
- SBSI United States
- MDXG United States
- Employees
- SBSI N/A
- MDXG N/A
- Industry
- SBSI Major Banks
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- SBSI Finance
- MDXG Health Care
- Exchange
- SBSI Nasdaq
- MDXG Nasdaq
- Market Cap
- SBSI 920.2M
- MDXG 1.0B
- IPO Year
- SBSI N/A
- MDXG N/A
- Fundamental
- Price
- SBSI $27.80
- MDXG $6.71
- Analyst Decision
- SBSI Hold
- MDXG Buy
- Analyst Count
- SBSI 3
- MDXG 1
- Target Price
- SBSI $34.50
- MDXG $12.00
- AVG Volume (30 Days)
- SBSI 134.8K
- MDXG 680.8K
- Earning Date
- SBSI 10-24-2025
- MDXG 10-29-2025
- Dividend Yield
- SBSI 5.20%
- MDXG N/A
- EPS Growth
- SBSI 4.30
- MDXG N/A
- EPS
- SBSI 2.81
- MDXG 0.21
- Revenue
- SBSI $254,956,000.00
- MDXG $363,774,000.00
- Revenue This Year
- SBSI $11.17
- MDXG $12.68
- Revenue Next Year
- SBSI $5.65
- MDXG $8.18
- P/E Ratio
- SBSI $9.86
- MDXG $31.51
- Revenue Growth
- SBSI 6.01
- MDXG 6.85
- 52 Week Low
- SBSI $25.85
- MDXG $5.59
- 52 Week High
- SBSI $38.00
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- SBSI 40.98
- MDXG 41.55
- Support Level
- SBSI $27.05
- MDXG $6.41
- Resistance Level
- SBSI $28.53
- MDXG $7.35
- Average True Range (ATR)
- SBSI 0.59
- MDXG 0.25
- MACD
- SBSI -0.02
- MDXG -0.05
- Stochastic Oscillator
- SBSI 36.78
- MDXG 26.06
About SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.